InsectSense, a Dutch biotechnology start-up specializing in objective taste measurement technology, secured €800k in pre-seed funding to advance its innovative ReceptomiX platform.
Information on the Target
InsectSense is an innovative biotechnology start-up based in Wageningen, The Netherlands. The company was founded by Aria Samimi (CEO) and Leon Schipper (CTO) and specializes in the development of ReceptomiX technology, which offers a groundbreaking method to measure taste properties objectively. The start-up has successfully developed the first version of this technology, which comprises a biochip utilizing human and insect receptors, a benchtop device for signal reading, and accompanying software for data interpretation.
With the recent closure of an €800k pre-seed funding round, InsectSense aims to prepare its ReceptomiX technology for market introduction, enhance its organizational capabilities, and further innovate its equipment and software. This funding round included investments from Capricorn Partners, Oost NL, and an angel investor, underscoring the confidence in InsectSense’s potential within the food technology sector.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Netherlands
The food technology industry in the Netherlands is known for its advanced research and innovation capabilities. As one of the largest exporters of food products in the world, the country enjoys a robust infrastructure that su
Similar Deals
NLC Health Ventures → NeurOdys Therapeutics
Capricorn Partners, Oost NL and an angel investor → InsectSense
Lead Ventures, J&T Ventures → XUND
2025
Capricorn Partners, Oost NL, Angel Investor
invested in
InsectSense
in 2023
in a Pre-Seed Stage deal
Disclosed details
Transaction Size: $1M